Lipid Insights

52 Episodes

Reverse

S7E14: Lp(a) After HORIZON: What the Results Mean for Cardiovascular Prevention

2026-11-1033:00

The primary results from the Lp(a)HORIZON trial were presented at the AHA Scientific Sessions in Chicago on November 7, 2026. Although pelacarsen lowered lipoprotein(a) [Lp(a)] levels, the trial did not reduce the risk of major adverse cardiovascular events (MACE). Lp(a) remains an important and independent risk factor for ASCVD, so what comes next? In this Lipid Insights episode, host Peter H. Jones, MD, MNLA sits down with two leading Lp(a) experts, Michael B. Boffa, PhD, and Marlys L. Kosc...

From Cholesterol to Dyslipidemia: Achieving Lipid Goals: From Clinical Strategy to Real-World Practice | Episode 3

2026-10-3136:32

From Cholesterol to Dyslipidemia: Translating the 2026 Multi-Society Guideline into Clinical Practice | Month 3 Podcast Knowing the guidelines is one thing. Putting them into practice is another. In the third installment of this four-part CME/CE-accredited series, the conversation shifts from risk assessment to treatment — tackling the clinical decisions that define how we manage patients with dyslipidemia day to day. This episode covers the new lipid treatment targets established by the 20...

S7E13: "Sterology" 101: A Deep Dive into Cholesterol and the Sterol Family with Dr. Lipid

2026-10-2128:50

What do we really know about cholesterol... and what are we missing? In this Lipid Insights episode, host Peter H. Jones, MD, MNLA sits down with Thomas Dayspring, MD, FACP, MNLA — widely known as “Dr. Lipid” — for a deep dive into the world of sterols and what Dr. Dayspring has coined “sterology.” Dr. Dayspring breaks down why cholesterol is so fundamentally important to cellular function, how cells defend against excess cholesterol buildup, how gut microflora influence cholesterol absorptio...

S7E12: Lipid Insights × The Tell-Tale Heart: Lipid Management in 2026

2026-10-0945:41

Two podcasts. One conversation. A meeting of minds at the intersection of lipidology and cardiovascular pharmacy. In this special collaboration episode, Lipid Insights joins forces with The Tell-Tale Heart: The Pharmacist's Cardiovascular Digest for a wide-ranging discussion on where lipid management stands today and where it's heading. Host Craig J. Beavers, PharmD sits down with NLA Executive Council Chair Michael J. Wilkinson, MD, FNLA for a conversation that every cardiovascular clinician...

From Cholesterol to Dyslipidemia: Beyond LDL: The Biomarkers That Matter | Episode 2

2026-09-3030:35

From Cholesterol to Dyslipidemia: Translating the 2026 Multi-Society Guideline into Clinical Practice | Month 2 Podcast LDL-C alone doesn't tell the whole story, and the 2026 Multi-Society Dyslipidemia Guideline makes that clear. In the second installment of this four-part CME/CE-accredited series, host Kaye-Eileen Willard, MD, FNLA sits down with Jessica Peña, MD, FNLA and Ann Marie Navar, MD, PhD to dig into the biomarkers reshaping cardiovascular risk assessment: ApoB vs. LDL-C discordanc...

#box-pro-ellipsis-179433902317399{-webkit-line-clamp:2;}Lipid Insights